Theglobal 'dermatophyticonychomycosis treatment market size‘ is predicted to reach USD 6.63billion by 2027, exhibiting a CAGR of 7.4% during the forecast period. Therising prevalence of diabetes and incidences of chronic nail fungus infectionwill lead to heavy demand for dermatophytic onychomycosis treatment, which, inturn, will foster the growth of the market, it is mentioned in a report, titled“Dermatophytic Onychomycosis Treatment Market Size, Share & COVID-19 ImpactAnalysis, By Product Type (Tablets and Nail Paints), By Route of Administration(Oral and Topical), By Type (Prescribed and Over-the-Counter (OTC)), ByDistribution Channel (Hospitals & Clinics, Retail Pharmacies, and OnlineChannels), and Regional Forecast, 2020-2027” the market size stood at USD 3.74billion in 2019.
Have Any Query? Ask Our Experts:
Regional Analysis:
Increasing Prevalence of Onychomycosis to Aid Expansion in NorthAmerica
Themarket size in North America stood at USD 1.65 billion in 2019. The growth inthe region is attributed to rising cases of onychomycosis in the region. Thegrowing R&D activities will further foster the growth of the market in theregion. The increasing demand for Jublia will accelerate the growth of themarket in the region. Europe is predicted to witness a high growth rate duringthe forecast period owing to the favorable health reimbursement policies inEuropean countries such as Italy, Spain, and the U.K. The superior distributionof OTC drugs retail pharmacies such as Walgreens, and others will enable speedyexpansion of the market in Europe. According to an article published in theJournal of the European Academy of Dermatology and Venereology, the prevalenceof onychomycosis in Europe is 4.3%.
AsiaPacific is expected to rise tremendously in the forthcoming years due to thenew product launches. The increasing prevalence of diabetes will spuropportunities for the market in the foreseeable future. The rising geriatricpopulation will further improve the growth prospects of the market. Inaddition, the rising patient awareness and developing healthcare infrastructurein emerging economies will boost the market.
Frequently Ask Question :
1) What was the value of theglobal dermatophytic onychomycosis treatment market in 2019?
Thevalue of the global dermatophytic onychomycosis treatment market was USD 3.74billion in 2019.
2) How much is the globalmarket worth?
FortuneBusiness Insights says that the market is projected to reach USD 6.63 billionby 2027.
3) What was the value of themarket in North America in 2019?
The value ofthe market in North America was USD 1.65 billion in 2019.
The report on the Dermatophytic Onychomycosis Treatment MarketReveals:
- Future insights into the industry
- An all-encompassing study of market size;
- In-detail data on all the segments
- Evidential information about competitors and prominent players
Market Driver:
Emergence of Topical Treatment Solutions to Augment Growth
Thegrowing cases of liver damage in patients will lead to a high demand for themarket in the near future. According to a survey conducted on dermatologistsand podiatrists in the U.S. by Moberg Pharma AB in 2017, 7 out of 10 doctorsavoid prescribing oral terbinafine owing to the risk of liver damage. Theinnovation and development of topical treatment solutions and oral anti-fungaldrugsassociated with liver damage will subsequently enable speedy expansion ofthe market. The rising need for improved topical solutions will impeldermatologists and podiatrists to present new theories for drug enhancement,which, in turn, will augur well for the market. Moreover, the increasing adoptionof nail lacquerswill consequently create new opportunities for the marketduring the forecast period. In addition, the increasing spending on R&Dactivities by major players will have a tremendous impact on the market in theforeseeable future.
An Overview of the Impact of COVID-19 on this Market :
Theemergence of COVID-19 has brought the world to a standstill. We understand thatthis health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments andseveral companies can help in the fight against this highly contagious disease.There are some industries that are struggling and some are thriving. Overall,almost every sector is anticipated to be impacted by the pandemic.
Weare taking continuous efforts to help your business sustain and grow duringCOVID-19 pandemics. Based on our experience and expertise, we will offer you animpact analysis of corona virus outbreak across industries to help you preparefor the future.
For more information visit : https://www.fortunebusinessinsights.com/dermatophytic-onychomycosis-treatment-market-103310
Table of Content:
Report Introduction
Market Introduction
- Definition
- Scope Of The Study
- Research Objective
- Assumptions
- Limitations
Research Methodology
- Introduction
- Primary Research
- Secondary Research
- Market Size Estimation
Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends & Assessment
Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Continue...
Key Development:
December 2019: Moberg Pharma, a Swedishpharmaceutical company announced that M0B-015, topical terbinafine under phase3 clinical study has met the primary and secondary endpoint for the treatmentof onychomycosis.
The Report Lists the Main Companies in the DermatophyticOnychomycosis Treatment Market:
- Bausch Health Companies Inc.
- Pfizer Inc.
- Galderma
- GlaxoSmithKline plc
- Janssen Pharmaceuticals, Inc.
- Cipla Inc.
- Kaken pharmaceuticals Co., Ltd.
- Other Prominent Players
Request a Sample Copy of the Research Report:
Global Dermatophytic Onychomycosis Treatment Market Segmentation :
By Product Type
Tablets
NailPaints
By Route of Administration
Oral
Topical
By Type
Prescribed
Over-the-Counter(OTC)
By Distribution Channel
Hospitals& Clinics
RetailPharmacies
OnlineChannels
By Geography
NorthAmerica (the U.S. and Canada)
Europe(U.K., Germany, France, Italy, Spain, Scandinavia, Russia, and Rest of Europe)
Asia-Pacific(Japan, China, India, Australia, New Zealand, Southeast Asia, andRest of Asia-Pacific)
Restof World
Related Reports:
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accuratedata, helping organizations of all sizes make timely decisions. We tailorinnovative solutions for our clients, assisting them to address challengesdistinct to their businesses. Our goal is to empower our clients with holisticmarket intelligence, giving a granular overview of the market they areoperating in.
Our reports contain a unique mix of tangible insights and qualitative analysisto help companies achieve sustainable growth. Our team of experienced analystsand consultants use industry-leading research tools and techniques to compilecomprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrativegrowth opportunities for our clients. We, therefore, offer recommendations,making it easier for them to navigate through technological and market-relatedchanges. Our consulting services are designed to help organizations identifyhidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:
sales@fortunebusinessinsights.com
